[2] By the early 1930s, she had established a reputation as one of Germany's leading pharmacologists, and in 1931, aged just 28, was appointed head of the chemical division at the Kaiser Wilhelm Institut für Hirnforschung ("Brain Science").

With Nazism on the rise throughout Germany, Vogt and other German scientists (including Edith Bulbring), decided that a move to Britain would be greatly beneficial, and in 1935 she arrived on a Rockefeller Travelling Fellowship in England.

Vogt joined the British Pharmacological Society and began work with Sir Henry Dale at the National Institute for Medical Research, London.

[7] Sir Henry Dale was awarded the Nobel Prize for Physiology or Medicine in 1936 based on the work described in this paper, and he credited Feldberg and Vogt in his lecture.

[8] In late 1935, for the second half of her Rockefeller Traveling Fellowship, Marthe Vogt began work in Cambridge on the relationship of blood pressure to substances from the ischaemic kidney with Professor E.B.

Her German nationality led to an investigation by British intelligence services in 1940, who categorized her as a category A enemy alien because Nazi officials would not accept her resignation from a permanent appointment when she left Germany.

In 1947, Vogt became a lecturer and later reader in pharmacology at Edinburgh University, where she continued work on transmitter substances, publishing research on serotonin and reserpine.